The deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company, with Mylan's shareholders owning slightly more than 40%, said the person, who declined to be named because the plans aren't yet public. The Wall Street Journal first reported the news.
The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will receive a new name and be domiciled in the U.S. The deal will be structured in what's known as a reverse Morris trust, with Pfizer's Upjohn business divested and then combined with Mylan.Pfizer doesn't break out numbers for its China-based Upjohn unit
. Pfizer's so-called Essential Health business, comprising off-patent drugs, branded generics, sterile-injectable medicines, biosimilars and others, drew $20.2 billion of the company's total $53.6 billion in 2018 sales, but Pfizer's not spinning off the entire unit. Mylan's stock is down 76% from its 2015 high amid scrutiny of its price increases on the EpiPen, pressure on U.S. generic drug prices and an investigation into drug-price collusion in the industry. The deal is the "best-case outcome" for Mylan, said Jared Holz, health-care strategist at Jefferies. Mylan said last year it had formed a strategic review committee to evaluate options for the future of the company.
Pfizer investors are more mixed on the deal, according to Holz, who said he's received feedback from shareholders since the Journal's first reportIt would mark a further move under new Chief Executive Albert Bourla to streamline Pfizer's focus on branded medicines and vaccines.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Pfizer and Mylan reportedly near merger deal for low-priced drugsOne company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. You went crazy over sprint and t-mobile yesterday but this is a big win ? This proves beyond a shadow of a doubt where your priorities lays. Not a peep out of democrats and you reporting it as a good deal. This is a shame. This is why we have President Trump. Nonononononononono Hmmm, with lesser competition, it's easier for big corporations to dictate and control prices. I hope this low-price drug market goal is going to happen.
Источник: CNN - 🏆 4. / 95 Прочитайте больше »
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Seriously can we STOP all the mega mergers Mylan was the one that increased the compensation of CEO HeatherBresch (daughter of FakeDem JoeManchin) 600% while jacking up the price of the lifesaving Epipen 400%.
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »